Related Experiment Video

Updated: Mar 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs

Julie Butters1, Alex Brown1, Liddy Griffith1

  • 1South Australian Health and Medical Research Institute, University of Adelaide, PO Box 11060, Adelaide, SA, 5001, Australia.

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|April 23, 2017
PubMed

Insights

New therapies are needed for cardiovascular prevention due to residual risk from low-density lipoprotein cholesterol (LDL-C). Many lipid-modifying drugs fail in trials, highlighting the need for careful outcome measure selection in clinical studies.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Clinical Trial Design

Background:

  • Statins are primary for cardiovascular prevention but residual risk persists.
  • Low-density lipoprotein cholesterol (LDL-C) and other lipoproteins contribute to this residual risk.
  • Novel lipid-modifying therapies are under development to address this gap.

Purpose of the Study:

  • To review factors influencing outcome measure selection in clinical trials of novel lipid-lowering therapies.
  • To analyze the evaluation spectrum of lipid-modifying drugs.
  • To understand the impact of trial design on results and interpretation.

Main Methods:

  • Literature review of clinical trial outcome measure selection.
  • Analysis of the evaluation spectrum for lipid-modifying drugs.
  • Discussion of trial design elements and their influence on interpretation.

Main Results:

  • Several lipid-modifying therapies have not reduced cardiovascular events in statin-treated patients.
  • Trial evaluations range from lipid parameters to plaque effects and clinical outcomes.
  • Clinical trial design significantly impacts study results and their interpretation.

Conclusions:

  • Careful consideration of outcome measures is crucial for evaluating new lipid-lowering therapies.
  • The design of clinical trials must be optimized to accurately assess therapeutic efficacy.
  • Addressing residual cardiovascular risk requires refined strategies in drug development and clinical evaluation.

More Related Videos

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

2.1K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
529
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
508
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
710